Related Experiment Video

Updated: Aug 13, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Behavioural intervention in the management of compliance in young type-I diabetics

P Matam1, V Kumaraiah, C Munichoodappa

  • 1Department of Clinical Psychology, NIMHANS, Bangalore.

The Journal of the Association of Physicians of India
|February 24, 2001
PubMed

Insights

A behavioral intervention significantly improved compliance, metabolic control, diabetes knowledge, and quality of life in young patients with Type I diabetes. These positive effects were sustained at a three-month follow-up.

Area of Science:

  • Pediatric Endocrinology
  • Behavioral Medicine
  • Diabetes Management

Background:

  • Type I diabetes requires lifelong management, including adherence to treatment regimens.
  • Young patients with Type I diabetes often face challenges with compliance and metabolic control.
  • Behavioral interventions show promise in addressing these challenges.

Purpose of the Study:

  • To evaluate the effectiveness of a behavioral intervention program on compliance in young Type I diabetics.
  • To assess the impact of behavioral management on metabolic control in this population.
  • To determine the influence of behavioral intervention on diabetes knowledge and quality of life.

Main Methods:

  • A randomized controlled trial involving 40 young Type I diabetics (20 experimental, 20 control).
  • The experimental group received 15 individual behavioral intervention sessions.
  • Intervention components included counseling, relaxation, education, and cognitive strategies; assessments used psychological measures and HbA1c.

Main Results:

  • Significant improvements were observed in the experimental group for compliance and metabolic control (HbA1c).
  • The intervention also led to significant increases in diabetes knowledge and reported quality of life.
  • These improvements in compliance and metabolic control were maintained at three-month follow-up.

Conclusions:

  • Behavioral intervention is an effective addition to standard medical care for young Type I diabetics.
  • It notably improves compliance, metabolic control, diabetes knowledge, and quality of life.
  • The intervention offers a valuable approach for managing Type I diabetes in pediatric populations.
Abstract

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Static Strength Training Method for Type 2 Diabetic Mice03:17

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...